Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 03-Jun-22 4:12 PM View:  | Flechtner Jessica Baker Chief Scientific Officer | Genocea Biosciences, Inc. (GNCA) | 02-Jun-22 | Sale | 1,578 | $0.06 | $94.68 | (2%) 90.61K to 89.03K | |
| 03-Jun-22 4:11 PM View: | Clark William D President and CEO Director | Genocea Biosciences, Inc. (GNCA) | 02-Jun-22 | Sale | 4,023 | $0.06 | $241.38 | (1%) 308.4K to 304.38K | |
| 03-Jun-22 4:13 PM View: | Duvall Diantha CHIEF FINANCIAL OFFICER | Genocea Biosciences, Inc. (GNCA) | 02-Jun-22 | Sale | 1,355 | $0.06 | $81.30 | (2%) 76.74K to 75.39K | |
| 02-Jun-22 4:32 PM View: | Sumer Jacquelyn L CHIEF LEGAL & COMPLIANCE OFF | Genocea Biosciences, Inc. (GNCA) | 01-Jun-22 | Sale | 2,500 | $0.06 | $150.25 | (5%) 45.5K to 43.0K | |
| 02-Jun-22 4:31 PM View: | Clark William D President and CEO Director | Genocea Biosciences, Inc. (GNCA) | 31-May-22 | Sale | 117,244 | $0.06 | $7,233.96 | (28%) 425.64K to 308.4K | |
| 01-Jun-22 4:11 PM View: | Siber George Director | Genocea Biosciences, Inc. (GNCA) | 27-May-22 | Sale | 20,425 | $0.07 | $1,333.75 | (99%) 20.68K to 0.25K | |
| 26-May-22 4:11 PM View: | Duvall Diantha CHIEF FINANCIAL OFFICER | Genocea Biosciences, Inc. (GNCA) | 26-May-22 | Sale | 24,407 | $0.08 | $1,867.14 | (24%) 101.15K to 76.74K | |
| 26-May-22 6:29 PM View: | Sandell Scott D 10% Owner | Genocea Biosciences, Inc. (GNCA) | 25-May-22 | Sale Duplicate | 4,445,090 | $0.08 | $362,720.00 | (100%) 4.45M to 0 | |
| 26-May-22 6:16 PM View: | Baskett Forest 10% Owner | Genocea Biosciences, Inc. (GNCA) | 25-May-22 | Sale Duplicate | 4,445,090 | $0.08 | $362,720.00 | (100%) 4.45M to 0 | |
| 26-May-22 10:00 PM View: | Stapleton Raymond D Jr CHIEF TECHNOLOGY OFFICER | Genocea Biosciences, Inc. (GNCA) | 25-May-22 | Sale | 2,500 | $0.09 | $222.50 | (5%) 46.25K to 43.75K | |
| 26-May-22 6:21 PM View: | Chang Carmen 10% Owner | Genocea Biosciences, Inc. (GNCA) | 25-May-22 | Sale Duplicate | 4,445,090 | $0.08 | $362,720.00 | (100%) 4.45M to 0 | |
| 26-May-22 6:25 PM View: | Makhzoumi Mohamad 10% Owner | Genocea Biosciences, Inc. (GNCA) | 25-May-22 | Sale Duplicate | 4,445,090 | $0.08 | $362,720.00 | (100%) 4.45M to 0 | |
| 26-May-22 4:13 PM View: | Flechtner Jessica Baker Chief Scientific Officer | Genocea Biosciences, Inc. (GNCA) | 25-May-22 | Sale | 16,525 | $0.09 | $1,455.85 | (15%) 107.13K to 90.61K | |
| 26-May-22 6:26 PM View: | New Enterprise Associates 1... 10% Owner | Genocea Biosciences, Inc. (GNCA) | 25-May-22 | Sale | 4,445,090 | $0.08 | $362,720.00 | (100%) 4.45M to 0 | |
| 26-May-22 6:31 PM View: | Sonsini Peter W. 10% Owner | Genocea Biosciences, Inc. (GNCA) | 25-May-22 | Sale Duplicate | 4,445,090 | $0.08 | $362,720.00 | (100%) 4.45M to 0 | |
| 26-May-22 6:19 PM View: | Behbahani Ali Director 10% Owner | Genocea Biosciences, Inc. (GNCA) | 25-May-22 | Sale Duplicate | 4,445,090 | $0.08 | $362,720.00 | (100%) 4.45M to 0 | |
| 26-May-22 6:23 PM View: | Florence Anthony A. Jr. 10% Owner | Genocea Biosciences, Inc. (GNCA) | 25-May-22 | Sale Duplicate | 4,445,090 | $0.08 | $362,720.00 | (100%) 4.45M to 0 | |
| 26-May-22 6:32 PM View: | Walker Paul Edward 10% Owner | Genocea Biosciences, Inc. (GNCA) | 25-May-22 | Sale Duplicate | 4,445,090 | $0.08 | $362,720.00 | (100%) 4.45M to 0 | |
| 26-May-22 6:21 PM View: | Chang Carmen 10% Owner | Genocea Biosciences, Inc. (GNCA) | 24-May-22 | Sale Duplicate | 5,931,840 | $0.07 | $387,942.00 | (57%) 10.38M to 4.45M | |
| 26-May-22 6:25 PM View: | Makhzoumi Mohamad 10% Owner | Genocea Biosciences, Inc. (GNCA) | 24-May-22 | Sale Duplicate | 5,931,840 | $0.07 | $387,942.00 | (57%) 10.38M to 4.45M | |
| 26-May-22 6:26 PM View: | New Enterprise Associates 1... 10% Owner | Genocea Biosciences, Inc. (GNCA) | 24-May-22 | Sale | 5,931,840 | $0.07 | $387,942.00 | (57%) 10.38M to 4.45M | |
| 26-May-22 6:31 PM View: | Sonsini Peter W. 10% Owner | Genocea Biosciences, Inc. (GNCA) | 24-May-22 | Sale Duplicate | 5,931,840 | $0.07 | $387,942.00 | (57%) 10.38M to 4.45M | |
| 26-May-22 6:19 PM View: | Behbahani Ali Director 10% Owner | Genocea Biosciences, Inc. (GNCA) | 24-May-22 | Sale Duplicate | 5,931,840 | $0.07 | $387,942.00 | (57%) 10.38M to 4.45M | |
| 26-May-22 6:23 PM View: | Florence Anthony A. Jr. 10% Owner | Genocea Biosciences, Inc. (GNCA) | 24-May-22 | Sale Duplicate | 5,931,840 | $0.07 | $387,942.00 | (57%) 10.38M to 4.45M | |
| 26-May-22 6:32 PM View: | Walker Paul Edward 10% Owner | Genocea Biosciences, Inc. (GNCA) | 24-May-22 | Sale Duplicate | 5,931,840 | $0.07 | $387,942.00 | (57%) 10.38M to 4.45M | |
| 26-May-22 6:29 PM View: | Sandell Scott D 10% Owner | Genocea Biosciences, Inc. (GNCA) | 24-May-22 | Sale Duplicate | 5,931,840 | $0.07 | $387,942.00 | (57%) 10.38M to 4.45M | |
| 26-May-22 6:16 PM View: | Baskett Forest 10% Owner | Genocea Biosciences, Inc. (GNCA) | 24-May-22 | Sale Duplicate | 5,931,840 | $0.07 | $387,942.00 | (57%) 10.38M to 4.45M | |
| 05-Apr-22 8:13 AM View: | Aakalu Girish N CHIEF BUSINESS OFFICER | Genocea Biosciences, Inc. (GNCA) | 04-Apr-22 | Private Sale | 963 | $1.25 | $1,203.75 | (1%) 75.42K to 74.46K | |
| 05-Apr-22 8:17 AM View: | Duvall Diantha CHIEF FINANCIAL OFFICER | Genocea Biosciences, Inc. (GNCA) | 04-Apr-22 | Private Sale | 963 | $1.25 | $1,203.75 | (1%) 92.74K to 91.78K | |
| 05-Apr-22 8:18 AM View: | Flechtner Jessica Baker Chief Scientific Officer | Genocea Biosciences, Inc. (GNCA) | 04-Apr-22 | Private Sale | 1,212 | $1.25 | $1,515.00 | (1%) 97.41K to 96.19K | |
| 05-Apr-22 8:17 AM View: | Davis Thomas Andrew CHIEF MEDICAL OFFICER | Genocea Biosciences, Inc. (GNCA) | 04-Apr-22 | Private Sale | 1,091 | $1.25 | $1,363.75 | (2%) 69.42K to 68.33K | |
| 05-Apr-22 8:15 AM View: | Clark William D President and CEO Director | Genocea Biosciences, Inc. (GNCA) | 04-Apr-22 | Private Sale | 3,924 | $1.25 | $4,905.00 | (1%) 373.41K to 369.49K | |
| 17-Mar-22 4:12 PM View: | Flechtner Jessica Baker Chief Scientific Officer | Genocea Biosciences, Inc. (GNCA) | 16-Mar-22 | Sale | 3,349 | $1.10 | $3,683.90 | (3%) 100.75K to 97.41K | |
| 17-Mar-22 4:09 PM View: | Davis Thomas Andrew CHIEF MEDICAL OFFICER | Genocea Biosciences, Inc. (GNCA) | 16-Mar-22 | Sale | 2,717 | $1.10 | $2,988.70 | (4%) 72.14K to 69.42K | |
| 17-Mar-22 4:06 PM View: | Clark William D President and CEO Director | Genocea Biosciences, Inc. (GNCA) | 16-Mar-22 | Sale | 11,435 | $1.10 | $12,578.50 | (3%) 384.85K to 373.41K | |
| 17-Mar-22 4:04 PM View: | Aakalu Girish N CHIEF BUSINESS OFFICER | Genocea Biosciences, Inc. (GNCA) | 16-Mar-22 | Sale | 2,397 | $1.10 | $2,636.70 | (3%) 77.82K to 75.42K | |
| 17-Mar-22 4:11 PM View: | Duvall Diantha CHIEF FINANCIAL OFFICER | Genocea Biosciences, Inc. (GNCA) | 16-Mar-22 | Sale | 2,873 | $1.10 | $3,160.30 | (3%) 95.61K to 92.74K | |
| 17-Mar-22 4:09 PM View: | Davis Thomas Andrew CHIEF MEDICAL OFFICER | Genocea Biosciences, Inc. (GNCA) | 15-Mar-22 | Grant | 31,250 | -- | -- | 76% 40.89K to 72.14K | |
| 17-Mar-22 4:17 PM View: | Sumer Jacquelyn L CHIEF LEGAL & COMPLIANCE OFF | Genocea Biosciences, Inc. (GNCA) | 15-Mar-22 | Grant | 37,500 | -- | -- | 469% 8.0K to 45.5K | |
| 17-Mar-22 4:06 PM View: | Clark William D President and CEO Director | Genocea Biosciences, Inc. (GNCA) | 15-Mar-22 | Grant | 150,000 | -- | -- | 64% 234.85K to 384.85K | |
| 17-Mar-22 4:04 PM View: | Aakalu Girish N CHIEF BUSINESS OFFICER | Genocea Biosciences, Inc. (GNCA) | 15-Mar-22 | Grant | 31,250 | -- | -- | 67% 46.57K to 77.82K | |
| 17-Mar-22 4:11 PM View: | Duvall Diantha CHIEF FINANCIAL OFFICER | Genocea Biosciences, Inc. (GNCA) | 15-Mar-22 | Grant | 37,500 | -- | -- | 65% 58.11K to 95.61K | |
| 17-Mar-22 4:14 PM View: | Stapleton Raymond D Jr CHIEF TECHNOLOGY OFFICER | Genocea Biosciences, Inc. (GNCA) | 15-Mar-22 | Grant | 43,750 | -- | -- | 1750% 2.5K to 46.25K | |
| 17-Mar-22 4:12 PM View: | Flechtner Jessica Baker Chief Scientific Officer | Genocea Biosciences, Inc. (GNCA) | 15-Mar-22 | Grant | 43,750 | -- | -- | 77% 57.0K to 100.75K | |
| 16-Mar-22 10:00 PM View: | Clark William D President and CEO Director | Genocea Biosciences, Inc. (GNCA) | 01-Jun-21 | Market Sale | 2,080 | $2.23 | $4,638.40 | (< 1%) 288.08K to 286.0K | 51% |
| 16-Mar-22 10:00 PM View: | Aakalu Girish N CHIEF BUSINESS OFFICER | Genocea Biosciences, Inc. (GNCA) | 01-Jun-21 | Market Sale | 511 | $2.23 | $1,139.53 | (< 1%) 52.39K to 51.88K | 51% |
| 16-Mar-22 10:00 PM View: | Duvall Diantha CHIEF FINANCIAL OFFICER | Genocea Biosciences, Inc. (GNCA) | 01-Jun-21 | Market Sale | 511 | $2.23 | $1,139.53 | (< 1%) 63.0K to 62.49K | 51% |
| 16-Mar-22 10:00 PM View: | Flechtner Jessica Baker Chief Scientific Officer | Genocea Biosciences, Inc. (GNCA) | 01-Jun-21 | Market Sale | 643 | $2.23 | $1,433.89 | (< 1%) 68.58K to 67.94K | 51% |
| 16-Mar-22 10:00 PM View: | Davis Thomas Andrew CHIEF MEDICAL OFFICER | Genocea Biosciences, Inc. (GNCA) | 01-Jun-21 | Market Sale | 524 | $2.23 | $1,168.52 | (1%) 49.22K to 48.7K | 51% |
| 16-Mar-22 10:00 PM View: | Aakalu Girish N CHIEF BUSINESS OFFICER | Genocea Biosciences, Inc. (GNCA) | 02-Apr-21 | Market Sale | 925 | $2.71 | $2,506.75 | (2%) 53.32K to 52.39K | 60% |
